Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Right lateral orbitofrontal cortex inhibitory transcranial magnetic stimulation for treatment of refractory mood and depression.
Tadayonnejad R, Citrenbaum C, Ngo TDP, Corlier J, Wilke SA, Slan A, Distler MG, Hoftman G, Adelekun AE, Leuchter MK, Koek RJ, Ginder ND, Krantz D, Artin H, Strouse T, Bari AA, Leuchter AF. Tadayonnejad R, et al. Among authors: koek rj. Brain Stimul. 2023 Sep-Oct;16(5):1374-1376. doi: 10.1016/j.brs.2023.09.011. Epub 2023 Sep 15. Brain Stimul. 2023. PMID: 37716637 Free article. No abstract available.
A comparison of self- and observer-rated scales for detecting clinical improvement during repetitive transcranial stimulation (rTMS) treatment of depression.
Leuchter MK, Citrenbaum C, Wilson AC, Tibbe TD, Jackson NJ, Krantz DE, Wilke SA, Corlier J, Strouse TB, Hoftman GD, Tadayonnejad R, Koek RJ, Slan AR, Ginder ND, Distler MG, Artin H, Lee JH, Adelekun AE, Leuchter AF. Leuchter MK, et al. Among authors: koek rj. Psychiatry Res. 2023 Dec;330:115608. doi: 10.1016/j.psychres.2023.115608. Epub 2023 Nov 14. Psychiatry Res. 2023. PMID: 37984281
The effect of older age on outcomes of rTMS treatment for treatment-resistant depression.
Leuchter MK, Citrenbaum C, Wilson AC, Tibbe TD, Jackson NJ, Krantz DE, Wilke SA, Corlier J, Strouse TB, Hoftman GD, Tadayonnejad R, Koek RJ, Slan AR, Ginder ND, Distler MG, Artin H, Lee JH, Adelekun AE, Einstein EH, Oughli HA, Leuchter AF. Leuchter MK, et al. Among authors: koek rj. Int Psychogeriatr. 2024 Mar 25:1-6. doi: 10.1017/S1041610224000462. Online ahead of print. Int Psychogeriatr. 2024. PMID: 38525670
A pilot study of closed-loop neuromodulation for treatment-resistant post-traumatic stress disorder.
Gill JL, Schneiders JA, Stangl M, Aghajan ZM, Vallejo M, Hiller S, Topalovic U, Inman CS, Villaroman D, Bari A, Adhikari A, Rao VR, Fanselow MS, Craske MG, Krahl SE, Chen JWY, Vick M, Hasulak NR, Kao JC, Koek RJ, Suthana N, Langevin JP. Gill JL, et al. Among authors: koek rj. Nat Commun. 2023 May 24;14(1):2997. doi: 10.1038/s41467-023-38712-1. Nat Commun. 2023. PMID: 37225710 Free PMC article.
Neuromodulatory treatments for post-traumatic stress disorder (PTSD).
Koek RJ, Roach J, Athanasiou N, van 't Wout-Frank M, Philip NS. Koek RJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:148-160. doi: 10.1016/j.pnpbp.2019.01.004. Epub 2019 Jan 11. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 30641094 Review.
Theranostic pharmacology in PTSD: Neurobiology and timing.
Koek RJ, Luong TN. Koek RJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 2;90:245-263. doi: 10.1016/j.pnpbp.2018.12.001. Epub 2018 Dec 6. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 30529001 Review.
Neuromodulation for Treatment-Refractory PTSD.
Langevin JP, Koek RJ, Schwartz HN, Chen JWY, Sultzer DL, Mandelkern MA, Kulick AD, Krahl SE. Langevin JP, et al. Among authors: koek rj. Fed Pract. 2017 Mar;34(Suppl 2):20S-33S. Fed Pract. 2017. PMID: 30766304 Free PMC article.
31 results